Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.

The aim of the study is to demonstrate that "frail" patients, defined as having a CFS score greater than or equal to 5, and "severely" frail patients, defined as having a CFS score between \[6-7\] as defined by Bagshaw et al (14), constitute an independent risk factor (RF) for mortality. In the same way, as an exploratory study, we will try to find out whether clinical frailty constitutes a risk factor for extending the length of hospital stay, the risk of short/medium-term readmission, as has already been demonstrated for patients admitted to intensive care from all causes (15), or for impaired quality of life. The objective is to have a better understanding of the implications and outcomes associated with pre-hospital frailty in young critically ill patients. This analysis will also help to clarify prognoses and contribute to better decision-making on the intensity and proportionality of care, as well as providing better information and helping to manage the expectations of patients and their families in terms of survival prognosis and subsequent quality of life.

Participants needed: 200
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Centre Hospitalier de LensUpdated: May 8, 2026Locations: 5
Eligibility criteria

Patients aged ≥18 years and ≤ 65 years [+4]

Patient moribund on admission [+5]

Status: Recruiting

Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease. Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).

Participants needed: 60
Trial details
Age: 70+Biological sex: AllType: InterventionalSponsor: Centre Hospitalier de LensUpdated: May 8, 2026Locations: 1
Eligibility criteria

Male or female ≥ 70 ans [+2]

Person with legal protective measures [+7]